Personalized CRISPR-Based K-abe Therapy Using Genetic Scissors

Selvakumar SC , Preethi KA , Ross K , et al. CRISPR/Cas9 and next generation sequencing in the personalized treatment of cancer. Mol Cancer, 2022; 21(1):83; doi: 10.1186/s12943-022-01565-1

Biswash MAR , Siddique MAB , Shabuj MMH , et al. Advancing personalized cancer care: Integrating CRISPR/Cas9 with next-generation sequencing technologies. J Precis Biosci, 2024; 6(1):1–14.

Badowska KA . Allele specific genome editing for the treatment of retinitis pigmentosa. Thesis. 2022. Available from: https://iris.unitn.it/handle/11572/355261 doi: 10.15168/11572_355261

Shamsnajafabadi H , Kaukonen M , Bellingrath JS , et al. In silico CRISPR-Cas-mediated base editing strategies for early-onset, severe cone-rod retinal degeneration in three Crumbs homolog 1 patients, including the novel variant c.2833G>A. Genes (Basel), 2024; 15(5):625; doi: 10.3390/genes15050625

Musunuru K , Grandinette SA , Wang X , et al. Patient-specific in vivo gene editing to treat a rare genetic disease. N Engl J Med, 2025; 392(22):2235–2243; doi: 10.1056/NEJMoa2504747

Noroozi A , Barzegary A , Karimi A , et al. Carbamoyl phosphate synthetase I deficiency. In: Genetic syndromes: A comprehensive reference guide. Cham: Springer International Publishing; 2023. pp. 1–5.

Gropman AL , Komor AC . Personalized gene editing to treat an inborn error of metabolism. N Engl J Med, 2025; 392(22):2273–2276; doi: 10.1056/NEJMe2505721

Dilliard SA , Siegwart DJ . Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs. Nat Rev Mater, 2023; 8(4):282–300; doi: 10.1038/s41578-022-00529-7

Su K , Shi L , Sheng T , et al. Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation. Nat Commun, 2024; 15(1):5659; doi: 10.1038/s41467-024-50093-7

Stone D , Takeuchi R , Dulin H , et al. Serum factors create species-specific barriers to hepatic gene transfer by lipid nanoparticles in liver-humanized mice. Mol Ther Methods Clin Dev, 2025; 33(2):101470; doi: 10.1016/j.omtm.2025.101470

Babur MN . Harnessing CRISPR technology for precision gene editing: Innovations and ethical considerations. Multidiscip J Biochem, 2024; 1(1):1–7.

Perillat L , McFadyen A , Furlong P , et al. A conceptual model and practical guidance for the development, administration, and evaluation of individualized therapies. Front Med (Lausanne), 2025; 12:1493832; doi: 10.3389/fmed.2025.1493832